NCT00797641已完成不适用
European Survey of Non-Variceal Upper Gastro Intestinal Bleeding
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,500
- 试验地点
- 1
- 主要终点
- To describe clinical outcomes associated with current strategies of endoscopic and pharmacological treatment in several European countries, in respect of bleeding continuation, rebleeding, surgery and in-hospital mortality
研究概览
简要总结
The aim of this study is to assess the current management strategies in a pan-European "real-life" setting to uncover the unmet need in this area: non-variceal gastrointestinal bleedings.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients admitted to the hospital or inpatients with an overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia, as well as other clinical/laboratory evidences of acute blood loss from the upper GI tract
- •Evidence that an upper GI endoscopy was performed
- •The complete medical record is available for study related hospitalization.
排除标准
- 未提供
结局指标
主要结局
To describe clinical outcomes associated with current strategies of endoscopic and pharmacological treatment in several European countries, in respect of bleeding continuation, rebleeding, surgery and in-hospital mortality
时间窗: Up to 30 days after the episode (bleeding)
次要结局
- To describe clinical management and how this compares across countries and Hospital types(Up to 30 days after the episode (bleeding))
- To assess predictive factors for clinical management strategies and predictive factors related to clinical outcomes(Up to 30 days after the episode (bleeding))
- To assess health care resource consumption in patients admitted with non-variceal upper gastrointestinal bleeding and the main drivers(Up to 30 days after the episode (bleeding))
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.DiabetesDiabetes Mellitus, Type 2NCT02877355Novo Nordisk A/S55
已完成
不适用
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese PatientsRe-bleeding in NVUGIBNCT01292915AstraZeneca1,044
已完成
不适用
An Observational Study of Burden of Upper GI-Symptoms in CV Risk PatientsCardiovascular DiseaseNCT00681759AstraZeneca1,836
招募中
不适用
Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National CohortGastroenteropancreatic Neuroendocrine TumorRadiotherapyNCT06256705Assistance Publique - Hôpitaux de Paris80
已完成
不适用
Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using PradaxaAtrial FibrillationNCT02022020Boehringer Ingelheim220